On the other hand, strategies used to find targetable pathways in LKB1-mutated cancer, such as the use of FDA-drug or Crispr-CAS9 libraries screening have shown the possibility of using specific protein inhibitors to hit this cancer. The gene discussed is STK11; the disease is cancer.